Lung Toxicity Articles & Analysis
2 articles found
DXd has a better safety profile and optimal solubility to induce bystander-killing effects to kill neighboring cancer cells, which in heterogeneous tumors is an advantage, but with a short half-life to avoid off-target toxicity. ADC Toxicity The FDA approved gemtuzumab ozogamicin (Mylotarg) in 2000 for the treatment of patients with acute myeloid leukemia ...
I presented part of my doctoral research on how macrophages play a regulatory role in lung injury and fibrosis. During the meeting, I had several conversations with Dr. ...